ICTI Presents at DIAs 21st Clinical Data Management Symposium
March 27, 2006
Continuing ICTI’s effort to explore and communicate strategies surrounding the clinical trial process, ICTI’s Vice President of Information Technology, Fritz Haas and Associate Director of Biostatistics, Eva Miller, Ph.D., have been invited to present at DIA’s Annual Clinical Data Management Symposium.
This year’s conference, being held March 26-28, 2006 in Philadelphia, will include sessions in which Mr. Fritz Haas will speak on the topic of “Technology in Clinical Trials: The Right Tools for the Job”, and Dr. Miller will present on, “Teaming the Data Managers and Statistician: Planning and Teamwork Yields the Best Results.”
ICTI will be presenting their experiences on key aspects of system and process management. Exploring the relationship between data managers and statisticians is extremely important in creating the best strategies that will make for a successful clinical trial. In addition, changing the role of technology use and process flow optimization helps to facilitate the most user-friendly and efficient clinical trial. Both topics will provide a better understanding of how to approach eclinical processes and technology changes associated with the rapidly evolving eclinical environment.
Richard McCann, ICTI’s President, noted, “We are very enthusiastic to have the opportunity to share our thought leadership on the topic of innovative concepts that improve the quality and efficacy of the clinical data management process. We are delighted to have our capabilities and experience presented at this prestigious conference.”
About ICTI and Almac Sciences
ICTI is a division of Almac Sciences that specializes in interactive solutions to accelerate the clinical trials process and reduce the costs of clinical trials. Our solutions include Interactive Voice and Web Response Systems (iXRS) for patient randomization, dosing and clinical supply inventory management; iDiary phone-based patient diary data collection; iTrial EDC for electronic case report form (eCRF) data collection; and forecasting for clinical trials supplies planning.
Almac Sciences and its affiliated companies (CSS (Chemical Synthesis Services), CTS (Clinical Trial Services), ICTI (Interactive Clinical Technologies Incorporated), PDMS (Pharmaceutical Development and Manufacturing Services) and Almac Diagnostic Services) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.
Contact Jim Murphy or Meghan Adams US: 267-685-4284 / [email protected]